Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A J Veerman

Showing results (141-150 of 153) with videos related to

Pageof 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia. Results of protocol ALL VI from the Dutch Childhood Leukemia Study GroupA J Veerman, K Hählen, W A Kamps, et al.
Haematology and Blood Transfusion|January 1, 1990
Update of the cytogenetic study of childhood non-high-risk acute lymphocytic leukemia at diagnosis in protocol VI of the Dutch Childhood Leukemia Study GroupR M Slater, D F Smeets, A Hagemeijer, et al.
British Journal of Haematology|March 2, 1999
Different expression of glutathione S-transferase alpha, mu and pi in childhood acute lymphoblastic and myeloid leukaemiaM L Den Boer, R Pieters, K M Kazemier, et al.
Leukemia|January 1, 1997
Mutations in the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropeniaF Dong, D C Dale, M A Bonilla, et al.
Blood|November 11, 1999
Circumvention of methotrexate resistance in childhood leukemia subtypes by rationally designed antifolatesM G Rots, R Pieters, G J Peters, et al.
Klinische Padiatrie|September 3, 1999
Cellular drug resistance in acute myeloid leukemia: literature review and preliminary analysis of an ongoing collaborative studyG J Kaspers, C M Zwaan, A J Veerman, et al.
Blood|October 7, 2000
Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemiaC M Zwaan, G J Kaspers, R Pieters, et al.
Advances in Experimental Medicine and Biology|January 11, 2002
Thiopurine methyl transferase: activity and genotyping in patients with acute lymphoblastic leukemiaC Brouwer, J J Keizer-Garritsen, L H Lambooy, et al.
British Journal of Haematology|March 22, 2001
In vitro drug resistance and prognostic impact of p16INK4A/P15INK4B deletions in childhood T-cell acute lymphoblastic leukaemiaN L Ramakers-van Woerden, R Pieters, R M Slater, et al.
Blood|July 27, 2000
TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemiaN L Ramakers-van Woerden, R Pieters, A H Loonen, et al.
Pageof 16

Showing results (141-150 of 153) with videos related to

Sort By:
Pageof 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1996
High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia. Results of protocol ALL VI from the Dutch Childhood Leukemia Study GroupA J Veerman, K Hählen, W A Kamps, et al.
Haematology and Blood Transfusion|January 1, 1990
Update of the cytogenetic study of childhood non-high-risk acute lymphocytic leukemia at diagnosis in protocol VI of the Dutch Childhood Leukemia Study GroupR M Slater, D F Smeets, A Hagemeijer, et al.
British Journal of Haematology|March 2, 1999
Different expression of glutathione S-transferase alpha, mu and pi in childhood acute lymphoblastic and myeloid leukaemiaM L Den Boer, R Pieters, K M Kazemier, et al.
Leukemia|January 1, 1997
Mutations in the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropeniaF Dong, D C Dale, M A Bonilla, et al.
Blood|November 11, 1999
Circumvention of methotrexate resistance in childhood leukemia subtypes by rationally designed antifolatesM G Rots, R Pieters, G J Peters, et al.
Klinische Padiatrie|September 3, 1999
Cellular drug resistance in acute myeloid leukemia: literature review and preliminary analysis of an ongoing collaborative studyG J Kaspers, C M Zwaan, A J Veerman, et al.
Blood|October 7, 2000
Cellular drug resistance profiles in childhood acute myeloid leukemia: differences between FAB types and comparison with acute lymphoblastic leukemiaC M Zwaan, G J Kaspers, R Pieters, et al.
Advances in Experimental Medicine and Biology|January 11, 2002
Thiopurine methyl transferase: activity and genotyping in patients with acute lymphoblastic leukemiaC Brouwer, J J Keizer-Garritsen, L H Lambooy, et al.
British Journal of Haematology|March 22, 2001
In vitro drug resistance and prognostic impact of p16INK4A/P15INK4B deletions in childhood T-cell acute lymphoblastic leukaemiaN L Ramakers-van Woerden, R Pieters, R M Slater, et al.
Blood|July 27, 2000
TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemiaN L Ramakers-van Woerden, R Pieters, A H Loonen, et al.
Pageof 16